AbbVie
ABBV
ABBV
3,362 hedge funds and large institutions have $228B invested in AbbVie in 2024 Q1 according to their latest regulatory filings, with 218 funds opening new positions, 1,327 increasing their positions, 1,485 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2% more funds holding
Funds holding: 3,306 → 3,362 (+56)
1.31% less ownership
Funds ownership: 72.23% → 70.92% (-1.3%)
11% less repeat investments, than reductions
Existing positions increased: 1,327 | Existing positions reduced: 1,485
Holders
3,362
Holding in Top 10
222
Calls
$3.29B
Puts
$2.55B
Top Buyers
| 1 | +$1.82B | |
| 2 | +$651M | |
| 3 | +$568M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$566M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$420M |
Top Sellers
| 1 | -$6B | |
| 2 | -$447M | |
| 3 | -$414M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$333M |
| 5 |
Goldman Sachs
New York
|
-$316M |